Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

You're a bit confused I think. Let me help clarify:

From the 10-Q, Menon's position as an employee, specifically President of Research, was terminated on Sept 18:

"In addition, Dr. Menon’s employment with the Company was terminated on September 18, 2018. Dr. Menon continues to serve on the Company’s Board of Directors."

From the 8-K, Menon resigns from his board position:

"On December 11, 2018, Dr. Krishna Menon resigned from his position as a director of Innovation Pharmaceuticals Inc. (the “Company”), effective immediately. His resignation was not a result of any disagreement with the Company."

Prurisol is dead and gone. It should be mourned appropriately and then buried along with 2018.

They require the space for all of the many indications in the lab:

B-OM prep work for phase 3.
B-UP/UPS/IBD formulation efforts
B-HS preclinical work/formulation.
B-AD preclinical work/formulation.
B-Acne preclinical work/formulation.
B-Biofilms work.
K oral formulation.

There is a tremendous amount of potential in this pipeline and a huge amount of ongoing work. With the right partner you're going to be glad they held onto all that lab space.